14-100149510-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_206918.3(DEGS2):c.283G>A(p.Ala95Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000219 in 1,600,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_206918.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DEGS2 | NM_206918.3 | c.283G>A | p.Ala95Thr | missense_variant | 2/3 | ENST00000305631.7 | NP_996801.2 | |
DEGS2 | XM_006720043.4 | c.175G>A | p.Ala59Thr | missense_variant | 3/4 | XP_006720106.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DEGS2 | ENST00000305631.7 | c.283G>A | p.Ala95Thr | missense_variant | 2/3 | 1 | NM_206918.3 | ENSP00000307126 | P1 | |
DEGS2 | ENST00000553834.1 | c.83-2603G>A | intron_variant | 3 | ENSP00000450637 | |||||
DEGS2 | ENST00000557117.1 | n.315G>A | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152256Hom.: 0 Cov.: 35
GnomAD3 exomes AF: 0.00000895 AC: 2AN: 223476Hom.: 0 AF XY: 0.00000817 AC XY: 1AN XY: 122376
GnomAD4 exome AF: 0.0000228 AC: 33AN: 1448622Hom.: 0 Cov.: 38 AF XY: 0.0000292 AC XY: 21AN XY: 720058
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152256Hom.: 0 Cov.: 35 AF XY: 0.00 AC XY: 0AN XY: 74384
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at